+494.4%
CVS vs UMC
+141.7%
+352.7%
-64.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | UMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.2% | -1.3% | -3.9% | -5.0% |
| 7D | -9.1% | -13.2% | +4.1% | -7.5% |
| 30D | -11.6% | -30.5% | +18.9% | -7.7% |
| 3M | -13.7% | -24.5% | +10.8% | -11.3% |
| 6M | -14.1% | -17.0% | +2.9% | -14.2% |
| YTD | +5.7% | +80.7% | -75.1% | -6.6% |
| 1Y | +7.6% | +101.2% | -93.6% | -6.4% |
| 3Y | +32.4% | +103.1% | -70.8% | +13.1% |
| 5Y | +0.9% | +59.6% | -58.7% | -12.6% |
| 10Y | +49.9% | +1,104.2% | -1,054.3% | -10.5% |
| All | +494.4% | +141.7% | +352.7% | +230.1% |
Cumulative growth
Daily Returns
Daily percentage return beside UMC.
Daily Out/Under-Performance
Portfolio return minus UMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded UMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling